Quad Tendon vs BTB Graft for ACL Reconstruction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines two methods for reconstructing a torn ACL, using either a graft from the quadriceps tendon (Quad tendon) or the patellar tendon (BTB). The goal is to determine which method is more effective. Individuals diagnosed with an ACL injury and planning surgery may be suitable for this trial. Participants should be able to adhere to a physical therapy plan after surgery. As an unphased trial, this study allows participants to contribute to valuable research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both the Quad tendon and BTB (bone-patellar tendon-bone) grafts are safe choices for ACL (anterior cruciate ligament) reconstruction. Studies have found that the Quad tendon is safe, with few complications. For example, one study reported fewer post-surgery issues and a lower chance of re-tearing with the Quad tendon graft. Another study noted no tears of the Quad tendon during the study period.
The BTB graft is also a well-known and safe method for ACL reconstruction. Research indicates it is commonly used and considered safe. One study found no major difference in complication rates between the BTB and Quad tendon grafts, suggesting both options are similarly safe.
In summary, both the Quad tendon and BTB grafts are generally well-tolerated and have a strong safety record in ACL reconstruction procedures.12345Why are researchers excited about this trial?
Researchers are excited about using quad tendon and BTB tendon grafts for ACL reconstruction because each offers unique benefits. Unlike traditional hamstring grafts, the quad tendon graft provides a larger graft size, which may enhance stability and strength. On the other hand, the BTB tendon graft is valued for its bone-to-bone healing properties, which can potentially lead to a quicker and stronger integration with the knee joint. These graft options aim to improve recovery times and outcomes for patients needing ACL reconstruction.
What evidence suggests that this trial's treatments could be effective for ACL reconstruction?
This trial will compare the effectiveness of two graft options for ACL reconstruction: the quad tendon and the BTB (bone-patellar tendon-bone) grafts. Studies have shown that both grafts perform well for ACL reconstruction. Research suggests that the quad tendon, used in one arm of this trial, often enables a quicker return to sports and has a lower retear risk compared to other grafts. Data on the BTB graft, used in another arm, indicates that many individuals return to sports, with a retear rate of about 7.5%. Both grafts yield similar results in terms of patient satisfaction and complication rates. Overall, both options are considered successful for ACL repair.36789
Who Is on the Research Team?
Amit Momaya, MD
Principal Investigator
Department of Orthopaedic Surgery, University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for skeletally mature individuals under 40 with an ACL injury who are scheduled for autograft reconstruction. It's not suitable for those unlikely to follow physical therapy, needing multiple ligament reconstructions, or wanting to return to sports within 6 months. Pregnant or nursing persons can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ACL reconstruction surgery using either BTB or QT autografts
Post-operative Rehabilitation
Standard of care rehabilitation and mobility instructions are provided, with follow-up appointments at 2 weeks, 6 weeks, 3 months, 6 months, and 9 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12 months and 24 months
What Are the Treatments Tested in This Trial?
Interventions
- BTB
- Quad tendon
BTB is already approved in United States, European Union for the following indications:
- Anterior Cruciate Ligament (ACL) reconstruction
- Anterior Cruciate Ligament (ACL) reconstruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor